CMND up 16.4% on Sep 8 2026 with no filing that explains it
CMND+16.4%on Tue Sep 8 2026
Clearmind Medicine Inc. Common Shares was up 16.4% on the day at $1.35, ranked #1 on 580× its usual five-minute volume, when TapeRank recorded this unexplained move at 07:45 ET during the pre-market session.
WHAT THE ROW LOOKED LIKE
LAST1.35
DAY▲ 16.4%
5 MIN▲ 16.39%
5M RVOL580×
5M $VOL$336K
FLOAT*1.0M
RANK#1
SESSIONPRE-MARKET
* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
AI VERDICT
UNEXPLAINEDCONFIDENCE3/5
CMND is essentially flat pre-market despite a 67.5x surge in relative volume, even as the company disclosed Yale IRB approval enabling patient recruitment for its Phase I/II trial. The elevated volume with negligible price movement points to positioning or order flow rather than a price reaction to the news itself.
WHYA clinical trial regulatory milestone would typically be expected to move a micro-float stock meaningfully, but the price is up only 0.3% despite outsized volume, so the news and the move are mismatched in the opposite direction of a typical stretched case.
ANALYZED 07:43 ET · 1 MIN AGO · ANTHROPIC/CLAUDE-SONNET-5
FILINGS · 24H BEFORE THE MOVE
- 03:43 ET6-K — REPORT OF FOREIGN PRIVATE ISSUERSEC 6-K
SESSION LEVELS AT CAPTURE
VWAP1.22
HOD1.33
LOD1.11
OR HIGH—
OR LOW—
PREV CLOSE1.16
PM HIGH1.33
PM LOW1.11
GAP▲ 11.21% (indicated)
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO